Newsroom

News May 22, 2024

Coverage and new Special Authorization requirements for Chronic Weight Management products

Wegovy, a prescription drug that contains the same active ingredient as Ozempic (semaglutide), recently became available in Canada, prompting inquiries regarding coverage. While these drugs have the same active ingredient, Ozempic has been approved by Health Canada for treatment of Type II diabet...

Read More

November 29th, 2023

Two out of three Saskatchewan residents struggle with their health literacy: report

Read More

November 9th, 2023

Saskatchewan Blue Cross supports Food Banks of Saskatchewan during the holiday season

Read More

November 7th, 2023

Saskatchewan Blue Cross partners with Foundations & Learning Skills Saskatchewan to support Health Literacy

Read More

October 24th, 2023

Saskatchewan Blue Cross supports Lung Saskatchewan Long Term COVID Project

Read More

October 18th, 2023

Saskatchewan Blue Cross partners with Saskatoon Council on Aging to launch Nav-CARE

Read More

October 10th, 2023

Saskatchewan Blue Cross Supports Vital Services in Our Communities

Read More